Table 3.
Published risk of AVNRT recurrence in pediatric cohorts.
| First Author | Year | N | % SVT recurrence | Mean# follow-up duration, months | Mean# age, years | Ablation energy |
|---|---|---|---|---|---|---|
| Siebels18 | 2018 | 379 | 14 | 55 ± 40 | 13 | RF |
| Karacan17 | 2018 | 275 | 4 | 26 ± 14 | 11 | Cryo |
| Balli16 | 2018 | 109 | 1 | 13 ± 6 | 10 | Cryo |
| Tuzcu15 | 2017 | 125 | 10 (6-mm tip) 8 (8-mm tip) |
15 ± 8 | 14 | Cryo |
| Reddy14 | 2017 | 117 | 11 (control) 0 (voltage mapping) |
22 ± 17 (control) 15 ± 7 (voltage mapping) |
14 | Cryo |
| Backhoff13 | 2016 | 241 | 4–11, depending on duration of follow-up | 12–96 | 13 (median) | Cryo/RF |
| Reddy12 | 2015 | 239 | 1 | 48 ± 24 | 8 (young cohort) 15 (old cohort) | Cryo/RF |
| Kubus11 | 2014 | 205 | 9–16, depending on era | 14 (IQR 6–22) | 15 (median) | RF |
| Drago10 | 2014 | 202 | 11 | 18–25, depending on subject age | 12 | Cryo |
| Qureshi9 | 2013 | 51 | 2 | 31 ± 10 | 14 | Cryo |
| Das8 | 2012 | 246 | 7 | 24 ± 2 | 13 | Cryo |
| Silver7 | 2010 | 70 | 3 | 12 ± 3 | 15 | Cryo |
| Drago6 | 2010 | 74 | 7 | 30 (range 2–74) | 11 | Cryo |
| LaPage5 | 2010 | 61 | 7 | 36 ± 12 | 13 | Cryo |
| Fishberger4 | 2010 | 65 | 0 | 33 ± 17 | 12 | RF |
| Czosek3 | 2010 | 58 | 2 | 12 | 16 (median) | Cryo |
Cryo = cryoablation; RF = radiofrequency; ± denotes the reported standard deviation.
#
All data were drawn from the primary publication and rounded to the nearest whole number. Where median data were reported by the authors, data are reported here with interquartile range (IQR) or range instead of standard deviation.